Continuing Medical Education Questions: September 2021

Area of Science:

• Hepatology
• Cardiovascular Medicine
• Critical Care Medicine

Background:

• Budd Chiari Syndrome (BCS) is a rare hepatic vascular disorder characterized by hepatic venous outflow obstruction.
• In-hospital mortality in BCS patients remains significant, necessitating improved risk stratification tools.

Purpose of the Study:

• To develop and validate a predictive scoring model for in-hospital mortality in patients diagnosed with Budd Chiari Syndrome.
• To identify key clinical and laboratory parameters associated with mortality risk in BCS.

Main Methods:

• Retrospective analysis of a large patient cohort diagnosed with Budd Chiari Syndrome.
• Development of a logistic regression model incorporating significant predictors of in-hospital mortality.
• Validation of the model using internal datasets and assessment of its discriminatory power (e.g., AUC).

Main Results:

• The developed scoring model demonstrated good predictive accuracy for in-hospital mortality in BCS patients.
• Key predictors identified included specific clinical signs, laboratory values (e.g., liver function tests, coagulation parameters), and presence of complications.
• The model showed robust performance in distinguishing between patients with high and low risk of mortality.

Conclusions:

• The novel scoring model provides a valuable tool for clinicians to predict in-hospital mortality risk in patients with Budd Chiari Syndrome.
• Early identification of high-risk individuals allows for timely intervention and optimized patient management strategies.
• Further prospective validation is recommended to confirm the model's utility in diverse clinical settings.